Freemelt (FREEM) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
1 Jul, 2026Strategic focus and business development
Emphasizes a differentiated approach in additive manufacturing (AM) with open-source and modular machine design, targeting serial production and reduced cycle times.
Focuses on three core verticals: defense, energy (especially fusion), and medtech, all experiencing structural growth driven by geopolitical and demographic trends.
Achieved record order intake and invoicing in 2025, with 12 machines sold year-to-date and 40 machines installed globally.
Outsourced assembly to Scanfil for a more agile supply chain and established a technical advisory board to align with industry needs.
Entered the Chinese market, citing high AM adoption rates and strategic alignment with China’s fusion and medtech ambitions.
Fusion energy and technology advancements
Fusion energy is entering a new era, with significant private and public investment and rapid growth in the number of fusion companies globally.
Key breakthroughs include divertor technology, high-temperature superconducting magnets, and AI-driven plasma management.
Additive manufacturing, especially with tungsten, is critical for plasma-facing components in fusion reactors, offering improved heat resistance and lower tritium retention.
Freemelt’s AM tungsten components demonstrated about 30% less tritium fuel retention, a potential game-changer for fusion economics.
Ongoing projects with Fusion for Energy and other partners are progressing, with AM enabling complex geometries and high-performance materials.
Medtech and industrial applications
Orthopedic implant market is rapidly adopting AM, with expectations that 20% of implants will be AM-produced by 2032.
Proof-of-concept with a major implant OEM could drive demand for over 100 machines in a positive scenario, based on new applications and future growth.
AM’s competitiveness in large-scale production hinges on reducing cycle times, integrating into production lines, and lowering powder costs.
Dual sourcing strategies are in place for key components to ensure supply chain resilience.
Latest events from Freemelt
- First industrial eMELT sale, OEM order, and machine sales growth amid ongoing losses.FREEM
Q3 20248 Jul 2026 - Q2 saw high activity, new orders, and strategic partnerships despite a wider loss.FREEM
Q2 20248 Jul 2026 - Scaling up with 162% revenue growth, new funding, and global expansion in MedTech, defense, and fusion.FREEM
Investor update2 Jun 2026 - Q1 net sales rose 116% YoY, with strong margins and key sector collaborations advancing.FREEM
Q1 20265 May 2026 - Sales up 172% to SEK 54.5m, installed base up 40%, and strong growth in key sectors.FREEM
Q4 202519 Feb 2026 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days11 Jan 2026 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 202423 Dec 2025 - Record Q2 sales and global expansion drive strong growth and order intake.FREEM
Q2 202523 Nov 2025 - Record order book and SEK 90M rights issue drive growth in defense, energy, and MedTech.FREEM
Q1 202521 Nov 2025